Factors Affecting Levels of Antiretroviral Drug Adherence among Adult Patient Living with HIV in Public Health Facilities of Arba Minch Town, Southern Ethiopia: Using Cumulative Logit Model
Article Sidebar
Main Article Content
Abstract
Background: Adherence to antiretroviral therapy is essential to reduce the multiplication of the virus and improve disease outcomes. The studies have reported a range of factors influencing antiretroviral therapy adherence at various levels. Almost all studies were modeling the factors based on binary categorization of the adherence.
Objective: This study intended to determine the adherence level and its associated factors to antiretroviral therapy among adult people living with human immunodeficiency virus.
Methods: This study was a cross-sectional study that employed among 391 adult patients that were selected by simple random sampling. The cumulative Logit model was used to examine the associations between the outcome of antiretroviral therapy adherence and independent variables.
Results: The study participants with good level of antiretroviral therapy adherence (67.77%) were approximately four times higher than study participants with fair (17.39%) and good (14.83%) adherence levels. As the duration on ART changed from ≤12 months to >12 months, the odds of high adherence/less adherence increased with approximately 61% (p = 0.0347) across the full scale of adherence levels. The estimated odds of patients with a CD4 ≥ 200cells/mm3 was 1.65 (p = 0.0279) times toward poor level of antiretroviral therapy adherence than the estimated odds of patients with CD4 < 200cells/mm3. Study participants who have single marital status tending to have more poor level of adherence to antiretroviral therapy than patients with married marital status (p = 0.0003).
Conclusion: Levels of adherence to the antiretroviral therapy is significantly determined by the duration on antiretroviral therapy, the number of CD4 counts, the types of initial antiretroviral therapy regimens and the marital status of adult people living with HIV/AIDS.
Article Details
References
World Health Organization (WHO). Global Health Sector Strategy on HIV 2016–2021. Geneva, Switzerland; 2016.
Available:https://apps.who.int/iris/bitstream/handle/10665/246178/WHO-HIV-2016.05-eng.pdf?sequence=1
Joint United Nations Programme on HIV/AIDS (UNAIDS). Ending AIDS: Progress towards the 90-90-90 targets. Global AIDS Update; 2017.
Available:http://www.unaids.org/sites/default/files/media_asset/Global_AIDS_update_2017_en.pdf
Country/Regional Operational Plan (COP/ROP). Strategic Direction Summary, Ethiopia; 2017.
Available:https://www.pepfar.gov/documents/organization/272012.pdf
Joint United Nations Programme on HIV/AIDS, & Joint United Nations Programme on HIV/Aids. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDs; 2014.
Avaiable:https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf
Granich R, Gupta S, Hall I, Aberle-Grasse J, Hader S, Mermin J. Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review. PLoS Medicine. 2017; 14(4):e1002253.
Haas AD, Msukwa MT, Egger M, Tenthani L, Tweya H, Jahn A, Gadabu OJ, Tal K, Salazar-Vizcaya L, Estill J, Spoerri A. Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in Malawi's option B+ program. Clinical Infectious Diseases. 2016;63(9):1227-35.
Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Medicine. 2008;5(5):e109.
Chaiyachati KH, Ogbuoji O, Price M, Suthar AB, Negussie EK, Bärnighausen T. Interventions to improve adherence to antiretroviral therapy: A rapid systematic review. Aids. 2014;28:S187-204.
Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor–based HIV therapy and virologic outcomes. Annals of Internal Medicine. 2007;146(8): 564-73.
Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor–based HIV therapy and virologic outcomes. Annals of Internal Medicine. 2007;146(8): 564-73.
Mannheimer S, Friedland G, Matts J, Child C, Chesney M. Terry beirn community programs for clinical research on AIDS. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for Human Immunodeficiency Virus—infected persons in clinical trials. Clinical Infectious Diseases. 2002;34(8): 1115-21.
Edward L, Machtinger DRB. Adherence to HIV antiretroviral therapy: HIV InSite Knowledge Base chapter. University of California San Francisco 2006.
Available:http://hivinsite.ucsf.edu/InSite?page=kb-03-02-09
Markos E, Worku A, Davey G. Adherence to ART in PLWHA and Yirgalem Hospital, South Ethiopia. Ethiopian Journal of Health Development. 2008;22(2):174-9.
Tadios Y, Davey G. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia. Ethiopian Medical Journal. 2006;44(3):237-44.
HIV AIDS Prevention and Control Organization (HAPCO). Federal Democratic Republic of Ethiopia country progress report on the HIV response. Addis Ababa, Ethiopia; 2014.
Available:https://www.unaids.org/sites/default/files/country/documents/ETH_narrative_report_2014.pdf
Asmare M, Aychiluhem M, Ayana M, Jara D. Level of ART adherence and associated factors among HIV sero-positive adult on highly active antiretroviral therapy in Debre Markos Referral Hospital, Northwest Ethiopia. J Antivir Antiretrovir. 2014; 6(3).
Agresti, A. Categorical data analysis. Second edition. John Wiley and Sons, Inc., New Jersey; 2002.
Available:https://leseprobe.buch.de/images-adb/a4/9c/a49c1d9f-eb25-4fd0-8501-c2b95a294df4.pdf
Agresti A. Analysis of ordinal categorical data. Second edition. John Wiley and Sons, Inc., New Jersey; 2010.
Available:https://www.google.com/search?q=25.+Agresti%2C+A.+(2010).Analysis+of+Ordinal+Categorical+Data.+Second+edition.+John+Wiley+and+
Sons%2C+Inc.%2C+New+Jersey.&oq=25.+Agresti%2C+A.+(2010).Analysis+of+Ordinal+Categorical+Data.+Second+edition.+John+Wiley+and+Sons%
C+Inc.%2C+New+Jersey.&aqs=chrome..69i57.1350j0j9&sourceid=chrome&ie=UTF-8
Abera A, Fenti B, Tesfaye T, Balcha F. Factors influencing adherence to antiretroviral therapy among people living with HIV/AIDS at ART Clinic in Jimma University Teaching Hospital, Southwest Ethiopia. J Pharma Reports. 2015;1 (101):2.
Gebrezgabher BB, Kebede Y, Kindie M, Tetemke D, Abay M, Gelaw YA. Determinants to antiretroviral treatment non-adherence among adult HIV/AIDS patients in northern Ethiopia. AIDS Research and Therapy. 2017;14(1):16.
Mitiku H, Abdosh T, Teklemariam Z. Factors affecting adherence to antiretroviral treatment in harari national regional state, Eastern Ethiopia. Isrn Aids; 2013.
Irano ZA, Taye A, Tessema TT, Adane HT, Alemayehu CM. Determinants of non-adherence to antiretroviral therapy and modeling progression of adherence level: At Yirgalem Regional Hospital, Ethiopia. International Journal of Medical and Health Sciences Research. 2015;2(1):1-4.
Charurat M, Oyegunle M, Benjamin R, Habib A, Eze E, Ele P, Ibanga I, Ajayi S, Eng M, Mondal P, Gebi U. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: A longitudinal analysis for risk factors. PloS One. 2010;5(5):e10584.